meta|COVID-19
  • Dynamic meta-analysis of evidences about drug efficacy and safety
  • adjuvant therapies
  • anti-inflammatoty and immuno-therapy
  • antiandrogenic
  • antiviral and associated therapy
  • control
  • honey
  • miscellaneous
  • vaccines
  • Ad26.COV2.S A EFFACER
  • BBV152
  • BCG vaccination
  • CureVac
  • DNA vaccine
  • bacTRL-Spike
  • Inactivated virus vaccine
  • Covaxin, Bharat Biotech, Indian Council of Medical Research
  • Sinopharm Beijing (BBIBP-CorV)
  • Sinopharm Wuhan
  • SinoVac Biotech
  • Non replicating viral vector
  • CanSino
  • ChAdOx1 nCoV-19 (AstraZeneca Oxford)
  • JNJ-78436735 AD26 (Jonson
  • Sputnik V (Gam-COVID-Vac)
  • protein subunit vaccine
  • Anhui Zhifei Longcom
  • NVX-CoV2373 (Novavax)
  • RNA vaccine
  • Moderna COVID-19 vaccine
  • tozinameran (Pfizer/BIONTECH)
  • Sanofi/GSK recombinant protein vaccine
  • SCB-2019
  • virus-like particles vaccine
  • Medicago
  • Zy-Cov-D (Zydus Cadila)
  • COVID-19
  • COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  • COVID 19 outpatients
  • COVID-19 prophylaxis
  • infections other than COVID-19
  • preventing respiratory virus transmission